Sign Up to like & get
recommendations!
0
Published in 2018 at "PLoS ONE"
DOI: 10.1371/journal.pone.0193018
Abstract: Background Nivolumab improves the survival of advanced non-small cell lung cancer (NSCLC), but a significant number of patients still fail to benefit from this treatment. In this study, we evaluated the efficacy of the time-series…
read more here.
Keywords:
series behavior;
time series;
time;
marker ... See more keywords